DAWN WALKER: Open Payments
NPI 1912468505 · MC KENZIE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 36 payments from 14 companies in 2025. Trend: 2023 $502 · 2024 $2,206 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $149 |
| Axsome Therapeutics, Inc. | 3 | $107 |
| Lundbeck LLC | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Viatris Specialty LLC | 3 | $51 |
| Astellas Pharma US Inc | 2 | $36 |
| ABBVIE INC. | 2 | $29 |
| Dexcom, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: HETLIOZ, CAPLYTA, REXULTI, Auvelity, YUPELRI, Veozah, FANAPT, VRAYLAR.
Industry payments across TN — which companies pay providers there.
